Leading Innovation In Endoscopic Therapeutics : ESGE Days 2025 Congress Review
At ESGE Days 2025, Treatment Strategies visited the exhibition hall and caught up with Finemedix,
a company founded in 2009 by Prof. Seong Woo Jeon, a gastroenterologist expert.
Finemedix Co., Ltd is a Korean medical device manufacturer brand built on a prosumer (producer+ consumer) driven model
where medical professionals directly participate in product development.
This unique approach has allowed Finemedix to successfully localize and innovate a wide range of endoscopic therapeutic devices,
particularly for Endoscopic Submucosal Dissection (ESD) and Endoscopic Mucosal Resection (EMR) procedures.
Finemedix’s main product is its hybrid ESD knife, a groundbreaking tool designed for the treatment of gastric,
colorectal, and esophageal cancers. As the first in the world to integrate both an I-tip (for marking and incision) and
an O-tip (for pre-cut and dissection) into a single device, this innovation has significantly reduced actual
procedure time, lowered patient’s burden, and improved cost-efficiency.
Finemedix holds approximately 25 percent of market share in Korea, a testament to its clinical performance and value.
As of March 2025, Finemedix offers 27 products, 234 different production models and the company has
earned recognition globally for its technological excellence, achieving its first million dollar export milestone in 2021 and expanding
its footprint to 47 countries worldwide.
In addition to its product innovations, Finemedix also runs an annual global training program called
‘TED – Therapeutic GI Endoscopy and ESD training in Daegu’.
The program is dedicated to supporting and educating young endoscopists from around the world.
The next program is scheduled in the third quarter of 2025, continuing Finemedix’s
commitment to advancing global endoscopic education and clinical excellence.
In late 2024, Finemedix listed on the KOSDAQ (Korean stock market).
Positioning itself as a total solution provider in endoscopic procedures, Finemedix is evolving from a fast
follower to a first mover, continuing to lead the endoscopy field with clinically inspired, physician-driven innovation.
E-BOOK LINK ▼
http://viewer.zmags.com/publication/c921f078#/c921f078/23
Source: © Absolute Media Group Ltd t/a The Cambridge Research Centre.
All rights reserved. P23.
